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Abstract The tripeptide 8-L-ce-aminoadipyl-L-cysteinyl-D-valine 
(LLD-ACV) is synthesised by the multifunctional enzyme ACV 
synthetase integrating four steps of the penicillin and cephalo-
sporin biosynthetic pathway. Peptide synthesis follows the 
thiotemplate mechanism from intermediates bound as thioesters 
to the enzyme. The formation of 6-(L-a-aminoadipyl)-L-cystein-
yl-thioester in the absence of L-valine was shown by isolation of 
the enzyme-substrate complex and cleavage of the covalently 
bound intermediate with performic acid. The dipeptide was 
recovered as cysteic acid or cysteic acid oxime and detected by 
HPLC and MALDI-TOF mass spectrometry. We conclude that 
the first peptide bond is formed between 5-carboxyl of L-
aminoadipic acid and L-cysteine, followed by addition of the 
dipeptidyl intermediate to L-valine. 
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1. Introduction 
ACV synthetase forms the tripeptide 8-(L-cc-aminoadipyl)-L-
cysteinyl-D-valine (LLD-ACV) from the respective amino 
acids and ATP. The relatively easy purification of higher 
quantities of the enzyme from penicillin- or cephalosporin-
overproducing strains permits this reaction sequence to be 
used as a model system for mechanistic studies of peptide 
biosynthesis. 
The classical thiotemplate mechanism [1] proposed that 
after activation as aminoacyl adenylates the intermediates 
bound as thioesters are assembled by one central swinging 
arm, the cofactor 4 '-phosphopantethein. Molecular genetic 
analysis of peptide synthetase genes and affinity-labelling 
studies of the gramicidin S system showed the domain struc-
ture of these enzymes to contain this cofactor covalently at-
tached to each domain [2-4]. Peptide assembly is thus accom-
plished by transfer of acyl intermediates between adjacent 
*Corresponding author. Fax: (49) 30-3142-7695. 
E-mail: hans@cicsg.tk.tu-berlin.de 
Abbreviations: Aad, L-a-aminoadipic acid; LL-AC, 8-(L-a-aminoadi-
pyl)-L-cysteine; LLD-ACV, 8-(L-a-aminoadipyl)-L-cysteinyl-D-valine; 
ATP, adenosine triphosphate; Cys, cysteine; DTE, dithioerythritol; 
EDTA, ethylenediaminetetraacetic acid; D-Val, D-valine; HPLC, high-
pressure liquid chromatography; MALDI, matrix-assisted laser 
desorption ionisation; OPA, o-phtalaldehyde 
cofactors, and has been termed multiple cofactor model. 
This model predicts that all thioester intermediates are at-
tached covalently to the peptide synthetases and should be 
detectable by specific hydrolysis. 
The structural similarity of ACV to glutathion seemed to 
indicate a similar biosynthetic mechanism. In 1983 Adlington 
et al. [5] demonstrated the incorporation of radioactive-la-
belled amino acids into LL-AC and LLD-ACV in a crude 
extract. In a kinetic study Banko and Demain [6] have shown 
that the formation of LLD-ACV from the substrate amino 
acids proceeded faster than from LL-AC and valine, conclud-
ing the presence of a single multienzyme. The ACV synthetase 
from Aspergillus nidulans was then isolated by van Liempt et 
al., demonstrating adenylate formation of L-a-aminoadipic 
acid, L-cysteine and L-valine, and thioester at tachment of L-
cysteine and L-valine [7]. Later, the thioester formation of 
aminoadipic acid has been shown for the ACV synthetase 
from Streptomyces clavuligerus [8]. 
Recently Shiau et al. recovered O-methyl-seryl-D,L-valine 
and L-cysteinyl-D-valine in attempts to replace cysteine by 
O-methyl-L-serine and aminoadipic acid by glutamic acid, re-
spectively [9,10]. These dipeptides were formed in small 
amounts , while the respective tripeptides have not been de-
tected. F r o m these data a new biosynthetic model has been 
proposed, where first LL-cysteinyl-valine is synthesised, fol-
lowed by epimerization to LD-cysteinyl-valine and the forma-
tion of LLD-ACV. 
We have investigated enzyme-bound intermediates to deter-
mine directly the sequence of reactions. 
2. Material and methods 
2.1. Strains and culture conditions 
Cells of Acremonium chrysogenum C-10 were grown similarly as 
previously described for Aspergillus nidulans [7]. Fermentations were 
seeded with an overnight culture instead of spore suspension. The 
mycelia were harvested 40 h after inoculation before the period of 
transition to the stationary growth phase. The mycelia were washed 
with 0.8% NaCl solution, lyophilised and stored at —20°C under dry 
conditions. 
2.2. Enzyme purification 
All procedures were carried out at 0^1oC in succession. Dried my-
celia (50 g) were ground in a mortar with sand and stirred for 40 min 
in 1 1 of buffer A (100 mM Tris-HCl, pH 7.5, at 4°C, 10 mM DTE 
(Biomol), 1 mM EDTA, 50% glycerol). After 30 min of centrifugation 
in a Beckman centrifuge at lOOOOXg nucleic acids were precipitated 
by treatment for 20 min with dialysed Polyimin solution (BASF, 
Ludwigshafen, Germany), final concentration 0.1%. After centrifuga-
tion as above neutralised saturated ammonium sulfate solution was 
gradually added to the supernatant to a final concentration of 30% 
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saturation, stirred for 20 min and centrifuged. Subsequently ammo-
nium sulfate solution was added to the supernatant up to a concen-
tration of 45% and the pellet was dissolved after centrifugation in 
buffer B (25 mM Tris-HCl, pH 7.5, at 4°C, 0.1 EDTA, 2 mM 
DTE, 10% glycerol). If the suspension was turbid, it was dialysed 
for 1.5 h and centrifuged. The solution (7 ml) was applied to an 
AcA 34 (Serva) gel filtration column (3 X 50 cm). Fractions were an-
alysed by SDS-polyacrylamide gel electrophoresis for protein compo-
sition and frozen. The final enzyme concentrations were defined by 
Bradford [11] and the extinction coefficient method [12]. From the 
absorption at 280 nm a final enzyme concentration of 360 pmol/ml 
calculated, using the extinction coefficient for ACV synthetase of 
369280 M_1-cm_1. The Bradford procedure gave 365 pmol/ml with 
BSA as a standard. With an estimated purity of 85% from SDS-
PAGE, the concentration of ACV synthetase was estimated to 300 
pmol/ml. 
2.3. Thioester formation 
ACV synthetase (300 pmol) was incubated with 1 mM Aad, 1 mM 
Cys, 6 mM DTE, 40 mM Mg acetate, 8 mM ATP (final volume 1.2 
ml) for 30 min at 25°C. The enzyme was precipitated with TCA (final 
concentration 10%), centrifuged after 15 min and the pellet was 
washed twice with 10% TCA and once with 100% ethanol. The pellet 
was dissolved in performic acid (300 ul of 95-98% formic acid, Merck 
and 60 ul of 30% H2O2, Fluka; [13]) and dried in a vacuum centri-
fuge. The AC standard was prepared analogue to the enzyme sample. 
A defined amount of the dipeptide was dissolved in 300 u.1 of formic 
acid and 60 ul of H2O2 and dried in a vacuum centrifuge. This meth-
od was developed in analogy to the sample preparation for the clas-
sical TLC analysis of radioactively labelled intermediates as thioesters 
[14]. 
2.4. HPLC analysis 
Analysis of free amino groups was performed by precolumn deriva-
tization with OPA (chiral amino acid analysis kit, GROM, Germany) 
dissolving the dry pellet from the precipitation in 60 ul of water and 
loading 7.5 ul to the column. 
2.5. MALDI-TOF mass spectrometry 
All samples were analysed in 150 mg/ml dihydroxybenzoic acid in 
acetone and 0.1% trifluoroacetic acid. A mixture of 1 ul of matrix and 
1 ul of sample dissolved in 10 ul of water/ethanol (1:1) was prepared 
directly on the plate. The samples were analysed using a MALDI 
VOYAGER ELITE time of flight mass spectrometer from PerSeptive 
Biosystems (Framingham, MA) containing a nitrogen laser giving a 
337 nm output. The ions were accelerated with a voltage of 20 kV. 
Measurements were performed in the delayed extraction mode, allow-
Fig. 1. Chiral HPLC analysis with OPA derivatisation: (a) standard 
AC treated with perfomic acid; (b) AC product of ACV synthetase 
treated with performic acid after 30 min incubation; (c) ACV syn-
thetase treated with performic acid at t = 0; (d) water. The peaks at 
retention times around 7 and 12 min have not been identified but 
are also contained in control samples containing water instead of 
the intermediates. 
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Scheme 1: oxidation products of AC treated with performic acid 
COOH COOH 
I I 
H2N — CH CH2 CH2 CH2 — CO — NH — CH — CH2 SH 1 
+ CHOOOH 
COOH COOH 
+ CHOOOH 
COOH COOH 
I I 
HO — N = C CH2 C H 2 — C H 2 — CO — NH — CH — CH2 SO3H 3 
1 5-(L a-aminoadipyl)-L-cysteine (264,07 m/z) 
2 8-(L a-aminoadipyl)-L-cysteic acid (312,06 m/z) 
3 5-(L oc-aminoadipyfJ-L-cysteic acid oxime (326,05 m/z) 
Scheme 1. 
ing the determination of monoisotopic mass values. The mass spec-
trometer was used in the positive ion detection and reflector mode. 
3. Results 
To determine the order of peptide bond formation catalysed 
by ACV synthetase we have analysed covalently bound inter-
mediates interrupting the catalytic cycle by substrate deple-
tion. Conditions selected would permit enzymatic formation 
of ACV for at least 3 h at a constant rate [15]. Omission of the 
last amino acid valine was expected to lead to the accumula-
tion of either cysteinyl- or aminoadipyl-L-cysteinyl intermedi-
ates. The covalent intermediates were obtained by TCA pre-
cipitation, thioester bonds were cleaved by performic acid 
treatment, and analysis was carried out by HPLC with OPA 
detection. No variation in the product patterns was found 
varying the incubation times between 5 min and 1 h. Controls 
of the isolated ACV synthetase without incubation did not 
show significant peaks of intermediates in the case of the 
Aspergillus nidulans enzyme. In the elution pattern obtained 
a compound barely detectable at a retention time of 10.3 min 
without incubation increases upon charging with aminoadi-
pate and cysteine (Fig. 1). The same compound is obtained 
if a sample of 8-(L-oc-aminoadipyl)-L-cysteine is treated with 
performic acid. As shown in Scheme 1 oxidation of the dipep-
tide intermediate to the cysteic acid derivative (Scheme 1, 1) 
and further oxidation to the oxime (Scheme 1, 2) are expected 
to occur in performic acid [13,16]. For further identification 
the intermediates were subjected to MALDI-TOF mass spec-
trometry (Fig. 2). In both the treated control sample and the 
intermediate preparation peaks corresponding to 8-(L-oc-ami-
noadipyl)-L-cysteic acid oxime (326.05 Da) were observed. 
The method, however, did not permit detection of the cysteic 
acid derivative due to matrix interference. Even if dihydrox-
ybenzoic acid was replaced by an a-cyano-4-hydroxycinnamic 
acid matrix peaks occurred in the 312 Da region. The oxidized 
sample is concluded to contain both 8-(L-a-aminoadipyl)-L-
cysteic acid and the respective /V-oxime, the latter not being 
detectable as fluorescent derivative in HPLC. The molar ratio 
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Fig. 2. MALDI analysis with dihydroxy benzoic acid matrix: (a) standard AC oxime (M. 326,25); (b) AC product (M. 326,25) of ACV synthe-
tase treated with performic acid after 30 min incubation; (c) matrix dihydroxybenzoic acid. 
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Scheme 2: Reactions catalysed by ACV synthetase. 
El + A + ATP J± El(A-AMP) + PPi j± El-Sp ' -A + AMP (1) 
E2 + C + ATP ?± E2(C-AMP) + PPi J± E2-Sp2-C + AMP (2) 
Cl 
El -Spl-A — E2-Sp2-C -> E2-Sp2-C-A + El -SplH (3) 
E3 + V + ATP ?± E3(V-AMP) + PPi ?± E3-Sp3-V + AMP (4) 
C2 
E2-Sp2-C-A + E3-S p 3 -V^E3-S p 3 -V-C-A+E2-SPH (5) 
C2 
E2-Sp2-C*-A + E3-Sp3-V -► E3-Sp3-V-C* + E2-SPH (6) 
Ep3 TE 
E3-Sp3-V-C-A f± E3-Sp3-DV-C-A -► A-C-DV (7) 
Ep3 TE 
E3-Sp3-V-C 5± E3-Sp3-DV-C -^C-DV (8) 
Scheme 2. The synthetase consists of the three modules: El, E2 and 
E3. Each module is composed of an activation site forming the 
(amino) acyl adenylate, a carrier domain which is post-translational-
ly modified with 4'-phosphopantetheine (Sp), and a condensation 
domain (Cl, C2) or alternatively a structurally similar epimerization 
domain (Ep). Activation of aminoadipate (A) leads to an acylated 
enzyme intermediate, where A is attached to the terminal cysteamine 
of the cofactor (El-Spl-A) (1). Likewise activation of cysteine (C) 
leads to cysteinylated module 2 (2). For the condensation reaction 
to occur between aminoadipate as donor and cysteine as acceptor, 
both intermediates are thought to react at the condensation site of 
module 1 (Cl). Each condensation site is composed in analogy to 
the ribosomal peptide formation of an aminoacyl and a peptidyl 
site, and in this case of initiation the thioester of A enters the P-
site, while the thioester of C enters the A site. Condensation occurs 
and leaves the dipeptidyl intermediate AC at the carrier protein of 
the second module (3). The third amino acid valine is activated on 
module 3, and V is attached to the carrier protein 3 (4). Formation 
of the tripeptide occurs at the second condensation site C2, with the 
dipeptidyl-intermediate entering the P site, and the valinyl-intermedi-
ate the A site (5). The synthesis of dipeptides is seen as a side reac-
tion, where the cysteinyl-thioester enters the P site of C2, and this 
minor reaction seems to be favoured in the case of O-methyl-serine 
replacing C (C*), or if an unproductive glutamyl adenylate occupies 
the first module (6). A similar reaction occurs in the synthesis of 
poly-phenylalanine in the ribosomal system, where the phenylalanyl 
ester of tRNA enters the P site to initiate peptide synthesis. Finally 
epimerization of the tripeptide (or dipeptide) intermediate occurs at 
the epimerization site of module 3 (Ep3), and the stereospecific pep-
tide release is controlled by the thioesterase (TE) (7). This release 
occurs likewise with the dipeptide Cys-D-Val. Since the dipeptide 
0-methyl-serinyl-D,L-valine is released as a racemate, it is apparently 
not a substrate of the thioesterase, but is hydrolysed non-enzymati-
cally. 
of bound dipeptide as cysteic acid to ACV synthetase has 
been estimated to 0.27, but no final conclusion can be drawn, 
since the ratio of cysteic acid derivative to oxime is not 
known. A sample of Acremonium chrysogenum ACV synthe-
tase yielded a more significant peak of the oxidized dipeptide 
even without incubation with substrates (results not shown). 
4. Discussion 
The investigation of reaction intermediates in biosynthetic 
sequences operating with covalent intermediates poses detec-
tion and identification problems due to the availability of the 
respective multienzymes in the low picomolar range. Thus 
aminoacyl- and peptidyl-intermediates in non-ribosomal pep-
tide synthesis so far have been studied using radiolabeled sub-
strates and cochromatography by TLC [14,17-19]. We have 
attempted here to apply HPLC and mass spectrometry to 
(a) study non-labeled substrates for reasons of availability 
and (b) to obtain more detailed structural informations. 
Thioester intermediates may be distinguished by performic 
acid oxidation from oxygen esters [20]. The only modification 
described so far has been the formylation of amino groups 
[19]. The analysis of intermediates of ACV biosynthesis in-
volves di- and tripeptides containing both amino and thiol 
groups presumably susceptible to oxidation. It is known 
that the oxidation of amines to oximes by peroxide leads to 
the formation of barely soluble equimolar complexes of the 
oximes formed with the respective amines, and thus no com-
plete oxidation can be achieved [16]. The oxidation of cysteine 
and cysteine peptides generally proceeds in yields of 80-90%, 
and so far products besides sulfonic acids have not been iden-
tified [21]. We have shown here the presence of the 8-(L-O> 
aminoadipyl)-L-cysteic acid oxime, and indirect evidence for 
the cysteic acid derivative in HPLC. No evidence for the un-
modified peptide has been obtained. The level of charging has 
been estimated to at least 27%, but the ratio of oxime to 
cysteic acid derivative of the dipeptide, the hydrolytic stability 
of the dipeptide, and the possible occupation by cysteine have 
not been considered. In conclusion evidence is presented that 
ACV synthetase contains detectable amounts of 8-(L-oc-amino-
adipyl)-L-cysteine as a thioester, the amount of which is in-
creased upon incubation with the respective substrate amino 
acids and ATP. The rapid formation of this covalent inter-
mediate indicates this peptide to be formed first in the ACV 
biosynthetic cycle. 
The formation of 0-methyl-seryl-D,L-valine or cysteinyl-D-
valine in the presence of glutamic acid [9] indicates either a 
side reaction initiating peptide synthesis in position 2, or an 
N-terminal cleavage of either N-terminal aminoadipoyl or 
glutaminyl side chain of the respective tripeptide formed. 
Although prolonged incubation times were used (16 h), we 
would favour the first interpretation since intermediate starts 
leading to dipeptide formation have been observed recently in 
actiniomycin and cyclosporin forming multienzymes [22,23]. 
In addition, L-cysteinyl-D-valine is not a substrate for ACV 
biosynthesis [9], while 5-(L-a-aminoadipyl)-L-cysteine was 
found to be accepted as a substrate for adenylation and bio-
synthesis [6,24,25]. 
The current view of the reaction sequence of ACV synthe-
tase has been summarised in Scheme 2. Experimental demon-
stration of adenylate formation as well as thioester binding of 
oc-aminoadipic acid, cysteine and valine has been carried out. 
We here have shown that the dipeptidyl-thioester 8-(L-ce-ami-
noadipyl)-L-cysteine is an actual intermediate of ACV biosyn-
thesis, so that reactions 1-4 have been verified. The verifica-
tion of the intermediates of reactions 5-8 is currently 
investigated. 
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